BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 30200332)

  • 21. Neuroblastoma: an enigmatic disease.
    Brossard J; Bernstein ML; Lemieux B
    Br Med Bull; 1996 Oct; 52(4):787-801. PubMed ID: 9039732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridization.
    Altura RA; Maris JM; Li H; Boyett JM; Brodeur GM; Look AT
    Genes Chromosomes Cancer; 1997 Jul; 19(3):176-84. PubMed ID: 9218999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroblastoma: molecular pathogenesis and therapy.
    Louis CU; Shohet JM
    Annu Rev Med; 2015; 66():49-63. PubMed ID: 25386934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoblastoma and Neuroblastoma Predisposition and Surveillance.
    Kamihara J; Bourdeaut F; Foulkes WD; Molenaar JJ; Mossé YP; Nakagawara A; Parareda A; Scollon SR; Schneider KW; Skalet AH; States LJ; Walsh MF; Diller LR; Brodeur GM
    Clin Cancer Res; 2017 Jul; 23(13):e98-e106. PubMed ID: 28674118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Therapies for Relapsed and Refractory Neuroblastoma.
    Zage PE
    Children (Basel); 2018 Oct; 5(11):. PubMed ID: 30384486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications of Genomic Sequencing in Pediatric CNS Tumors.
    Bavle AA; Lin FY; Parsons DW
    Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroblastoma: biology, prognosis, and treatment.
    Park JR; Eggert A; Caron H
    Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroblastoma.
    Nakagawara A; Li Y; Izumi H; Muramori K; Inada H; Nishi M
    Jpn J Clin Oncol; 2018 Mar; 48(3):214-241. PubMed ID: 29378002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the diagnosis and treatment of neuroblastoma.
    Katzenstein HM; Cohn SL
    Curr Opin Oncol; 1998 Jan; 10(1):43-51. PubMed ID: 9466484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
    Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
    Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and treatment of the most common solid tumors in childhood.
    Marina NM; Krance R; Ribeiro RC; Crist WM
    Prim Care; 1992 Dec; 19(4):871-89. PubMed ID: 1334564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma.
    Oldridge DA; Truong B; Russ D; DuBois SG; Vaksman Z; Mosse YP; Diskin SJ; Maris JM; Matthay KK
    J Natl Cancer Inst; 2019 Nov; 111(11):1192-1201. PubMed ID: 30793172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
    Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
    Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.
    Trochet D; Bourdeaut F; Janoueix-Lerosey I; Deville A; de Pontual L; Schleiermacher G; Coze C; Philip N; Frébourg T; Munnich A; Lyonnet S; Delattre O; Amiel J
    Am J Hum Genet; 2004 Apr; 74(4):761-4. PubMed ID: 15024693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genetic alterations in neuroblastoma and their usefulness for clinical management].
    Normand C; Michon J; Janoueix-Lerosey I; Delattre O; Schleiermacher G
    Bull Cancer; 2011 May; 98(5):477-88. PubMed ID: 21609891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and epigenetic alterations in neuroblastoma.
    Tonini GP; Romani M
    Cancer Lett; 2003 Jul; 197(1-2):69-73. PubMed ID: 12880962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial neuroblastoma: a complex heritable disease.
    Tonini GP; Longo L; Coco S; Perri P
    Cancer Lett; 2003 Jul; 197(1-2):41-5. PubMed ID: 12880958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroblastoma: biology and therapy.
    Matthay KK
    Oncology (Williston Park); 1997 Dec; 11(12):1857-66; discussion 1869-72, 1875. PubMed ID: 9436190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.
    Bourdeaut F; Trochet D; Janoueix-Lerosey I; Ribeiro A; Deville A; Coz C; Michiels JF; Lyonnet S; Amiel J; Delattre O
    Cancer Lett; 2005 Oct; 228(1-2):51-8. PubMed ID: 15949893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer: germline prediction for a commonly variable malignancy.
    Bambury RM; Gallagher DJ
    BJU Int; 2012 Dec; 110(11 Pt C):E809-18. PubMed ID: 22974436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.